USPTO trademark

MIMRELSA

AllowedUSPTOWord markClass 5Class 42Class 44

"MIMRELSA" is a word mark owned by Protagonist Therapeutics, Inc., filed at the USPTO on November 29, 2022. It has been allowed and covers classes 5, 42 and 44.

Official USPTO record
MIMRELSA trademark as filed
As filed with the USPTO
Status
Allowed
Since July 22, 2026
Filed
November 29, 2022
Registered
Not yet
Expires
Not recorded
Application no.
97696650
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
3 classes
Ownership

Who owns MIMRELSA

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Goods and services

What the mark covers

The products and services MIMRELSA is filed for, grouped by Nice class.

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notice of approval of extension request e-mailed
  2. Sou extension 5 granted
  3. Case assigned to intent to use paralegal
  4. Sou extension 5 filed
  5. Sou teas extension received
  6. Teas withdrawal of attorney received-firm retains
  7. Teas change of correspondence received
  8. Attorney/dom.rep.revoked and/or appointed
  9. Teas revoke/app/change addr of atty/dom rep received
  10. Notice of approval of extension request e-mailed

10 earlier steps on the official record.

FAQ

About MIMRELSA

Who owns the trademark "MIMRELSA"?

The USPTO trademark "MIMRELSA" (application 97696650) is owned by Protagonist Therapeutics, Inc.

What is the status of "MIMRELSA"?

Its status at the USPTO is: allowed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull MIMRELSA and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

GET /v1/trademarks/{id}
ID=tm_019d2b27-6b6f-728d-8acb-05a91bd16828
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2b27-6b6f-728d-8acb-05a91bd16828",
  "object": "trademark",
  "mark_text": "MIMRELSA",
  "status": {
    "primary": "pending",
    "stage": "allowed"
  },
  "office_code": "US",
  "application_number": "97696650",
  "filing_date": "2022-11-29",
  "nice_classes": [
    5,
    42,
    44
  ],
  "owners": [
    {
      "name": "Protagonist Therapeutics, Inc.",
      "entity_id": "ent_019eb715-aaa5-750e-ab80-0f081fc9e674"
    }
  ]
}